US FDA approves BridgeBio's drug for rare heart condition
The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...
Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby
BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
We now know when a new COVID vaccine will be released. Should you get a booster?
Australia is set to get a new COVID vaccine in the next two weeks, but what variant is it targeting? And should we all still ...
The Motley Fool on MSN18h
3 Dividend Stocks That Are Screaming Buys in November
Political fears and a failed clinical trial have soured the market on AbbVie. The market is still punishing Pfizer for its ...
justthenews6h
Sen. Ron Johnson threatens legal action to get COVID-19 vaccine data
Your agencies’ refusal to provide complete and unredacted responses and documents to my numerous oversight letters on the ...
devdiscourse9h
Revolutionary Drug Approvals and Global Health Updates
The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...
Trump Announces Nominations for CDC, FDA, and Surgeon General
President-elect Donald Trump nominated his picks for Centers for Disease Control and prevention director, Food and Drug ...
Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate
Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...
Food Safety News18h
Food Safety News
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...